Forbes October 10, 2019
Joshua Cohen

Of the approximately 7,000 rare diseases 80% are genetic. And, more than half of rare diseases affect children.

For patients and their caregivers, one of the more frustrating aspects of rare diseases is the length of time from symptom onset to an accurate diagnosis, which averages 4.8 years.

Last month, together with several colleagues in the House, Representative Eric Swalwell of California reintroduced a bipartisan bill called Advancing Access to Precision Medicine Act. The legislation had originally been proposed in January 2018, and is aimed at promoting the use of genetic and genomic testing to improve healthcare delivery. Specifically, the bill is designed to improve patient access to genetic and genomic testing to help shorten the time to diagnosis, easing...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Patient / Consumer, Precision Medicine, Provider, Technology
Revolutionizing Primary Care: The Role of Pharmacogenomics and AI in Personalized Medicine
BioAro Announces Real Time DNA Decoding Technology
23andMe: What If …
23andMe CEO Anne Wojcicki considers taking company private
Age of Opportunity: Artificial Intelligence and the Precision Medicine Future

Share This Article